UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

Nature genetics, 2009-01, Vol.41 (1), p.71-76

2009

Link zum Volltext

Verfügbarkeit prüfen

Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection

Inflammatory bowel diseases, 2007-02, Vol.13 (2), p.135-142

2007

Link zum Volltext

Verfügbarkeit prüfen

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

Nature genetics, 2023-05, Vol.55 (5), p.796-806

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn’s disease

Digestive and liver disease, 2023-03, Vol.55 (3), p.366-372

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia

Clinical gastroenterology and hepatology, 2020-06, Vol.18 (7), p.1528-1536.e5

2020

Link zum Volltext

Verfügbarkeit prüfen

Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology

PLoS genetics, 2011-01, Vol.7 (1), p.e1001273-e1001273

2011

Link zum Volltext

Verfügbarkeit prüfen

Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection

2007-02

Link zum Volltext

Verfügbarkeit prüfen

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis

Gut, 2023-11, Vol.72 (11), p.2068

2023

Link zum Volltext

Verfügbarkeit prüfen

Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

Digestive and liver disease, 2023-12, Vol.55 (12), p.1632-1639

2023

Link zum Volltext

Verfügbarkeit prüfen

The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study

Journal of Crohn's and colitis, 2023-01, Vol.17 (1), p.37-48

2023

Link zum Volltext

Verfügbarkeit prüfen

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

Acta gastro-enterologica belgica, 2018-01, Vol.81 (1), p.49-53

2018

Link zum Volltext

Verfügbarkeit prüfen

The Tnf/Adam 17 System: Implication of an Adam 17 Haplotype in the Clinical Response to Infliximab in Crohn's Disease

Pharmacogenetics and genomics, 2006-10, Vol.16 (10), p.727-734

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

Acta gastro-enterologica belgica, 2015-01, Vol.78 (1), p.26-29

2015

Link zum Volltext

Verfügbarkeit prüfen

A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohnʼs disease

European journal of gastroenterology & hepatology, 1997-10, Vol.9 (10), p.939-944

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

ThemaFemale

ThemaCrohn's Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4

Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection

Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn’s disease

Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia

Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology

Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis

Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis

Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study

The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

The Tnf/Adam 17 System: Implication of an Adam 17 Haplotype in the Clinical Response to Infliximab in Crohn's Disease

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohnʼs disease

Aktive Filter

Suchergebnisse filtern